News
Israel’s CytoReason launches AI drug discovery platform in Japanese market
This is the first known collaboration between an Israeli company and a Japanese pharmaceutical company to bring AI to clinical drug development.
News
This is the first known collaboration between an Israeli company and a Japanese pharmaceutical company to bring AI to clinical drug development.